CCAM BIOTHERAPEUTICS

cCAM Biotherapeutics is a pre-clinical stage company developing immunotherapies for cancer. cCAM's lead agent, CM-10, is an immunomodulatory antibody that harnesses the patient's immune system to attack tumors. CM-10 binds CEACAM1, a protein used by cancer cells to suppress the immune system. CM-10 abrogates this effect, leading to a cancer specific immune response in patients.
CCAM BIOTHERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2009-01-01
Address:
Qiryat Shmona, HaZafon, Israel
Country:
Israel
Website Url:
http://www.ccam-bio.com
Total Employee:
11+
Status:
Closed
Contact:
972 4 681 8829
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Thawte SSL
Similar Organizations
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Current Employees Featured
Founder
Investors List
Arkin Holdings
Arkin Holdings investment in Series A - cCAM Biotherapeutics
OrbiMed
OrbiMed investment in Series A - cCAM Biotherapeutics
Pontifax
Pontifax investment in Series A - cCAM Biotherapeutics
Official Site Inspections
http://www.ccam-bio.com
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "cCAM Biotherapeutics"
cCAM Biotherapeutics - Crunchbase Company Profile & Funding
Sep 15, 2012 cCAM Biotherapeutics is a pre-clinical stage company that develops immunotherapies for cancer.See details»
cCAM Biotherapeutics Company Profile 2024: Valuation, Investors ...
CCAM Biotherapeutics General Information Description. Developer of novel immunotherapies for different cancer indications. The company's lead agent is CM-10, an immunomodulatory โฆSee details»
Merck Enhances Immuno-Oncology Portfolio with Acquisition of โฆ
Jul 28, 2015 About cCAM Biotherapeutics. Founded in 2010 and led by Tehila Ben-Moshe, Ph.D., cCAM is a biopharmaceutical company focused on the discovery and development of โฆSee details»
OBIO®
OBIO®, 108 College St., Suite W1020, Toronto, Ontario, Canada M5G 0C6 (416) 848 6839 [email protected]See details»
Merck Enhances Immuno-Oncology Portfolio acuiring cCAM
Jul 29, 2015 About cCAM Biotherapeutics Founded in 2010 and led by Tehila Ben-Moshe, Ph.D., cCAM is a biopharmaceutical company focused on the discovery and development of โฆSee details»
cCAM Biotherapeutics - Foreign Startup | Startup Nation Finder
Apr 20, 2015 cCAM Biotherapeutics is a preclinical-stage company focused on the discovery and development of novel immunotherapies to treat cancer. The company's lead product, CM โฆSee details»
BIO Member Directory
The contents of the member listings on the BIO Web site may not be reproduced or used in any form without prior written permission from BIO. For more information about members, please โฆSee details»
BIO Appoints Veteran Communications Leader Sarah Alspach as โฆ
16 hours ago Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications โฆSee details»
cCAM Biotherapeutics Announces Initiation of Phase 1 Trial of CM โฆ
Apr 23, 2015 Dr. Tehila Ben-Moshe, Chief Operation Officer, cCAM Biotherapeutics, stated, "We are pleased to have our CM-24 Phase 1 clinical trial underway.See details»
About BIO 2025 - BIO International Convention 2024
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. Whether you work at a public pharmaceutical โฆSee details»
OmniaBio Inc. Launch Announcement - CCRM
MaRS Centre, West Tower 661 University Avenue, Suite 1002 Toronto, Ontario M5G 1M1 Canada t: 416-978-3751 f: 416-978-1368See details»
Merck Enhances Immuno-Oncology Portfolio with Acquisition of โฆ
Jul 28, 2015 "Merck's excellence and leadership in immuno-oncology provides a strong foundation for advancing CM-24, for the treatment of people with cancer," said Pini Orbach, โฆSee details»
OmniaBioโs Impact and Future with Mitchel Sivilotti
Apr 27, 2024 Mitch Sivilotti, CEO of OmniaBio Inc., shared with CanadianSME Small Business Magazine how OmniaBio is propelling Canada to the forefront of cell and gene therapy (CGT) โฆSee details»
Climate Change Adaptation and Mitigation (CCAM) Team Leader
Oct 13, 2022 ICBA is seeking a Climate Change Adaptation and Mitigation (CCAM) Team Leader to join the Sustainable Natural Resources Management (SNRM) unit to accelerate the โฆSee details»
CCRM | Commercializing Living Therapies
CCRM is a catalyst for commercializing regenerative medicine-based technologies and cell and gene therapies. We enable product development through the unique translational platforms โฆSee details»
OmniaBio Inc. - CCRM
Organization (CDMO) for the manufacture of cell and gene therapies. OmniaBio will provide pivotal/Phase III and commercial-scale manufacturing of gene-modified cells and viral vectors โฆSee details»
OmniaBio, CCRM and Stakeholders Celebrate Commencement of โฆ
October 6, 2022 (Hamilton, ON) โ OmniaBio Inc., a commercial-stage contract development and manufacturing organization (CDMO) focused on cell and gene therapies (CGTs), has broken โฆSee details»
CCAM: Cooperative, connected & automated mobility - SWARCO
CCAM โ i.e. cooperative, networked and automated mobility โ will permanently change the traffic of the future and is one of the major future trends in the automotive industry.By gradually โฆSee details»
OmniaBio: Bringing Maturity to Cell and Gene Therapy (Drone Video)
MaRS Centre, West Tower 661 University Avenue, Suite 1002 Toronto, Ontario M5G 1M1 Canada t: 416-978-3751 f: 416-978-1368See details»
About Us - CCRM
By partnering with leading research institutions to launch new ventures, enabling industry by providing innovative contract development and manufacturing organization (CDMO) services โฆSee details»